The generalized myasthenia gravis treatment market is growing rapidly thanks to new immunotherapy agents including monoclonal antibodies and complement inhibitors, improving symptoms in patients with autoimmune neuromuscular disorders. https://www.datamintelligence.com/research-report/generalized-myasthenia-gravis-treatment-market